Mannatech, Incorporated (NASDAQ:MTEX – Get Free Report) was the recipient of a large decline in short interest in the month of December. As of December 15th, there was short interest totaling 11,621 shares, a decline of 22.7% from the November 30th total of 15,030 shares. Based on an average trading volume of 2,968 shares, the short-interest ratio is presently 3.9 days. Currently, 1.0% of the shares of the company are short sold. Currently, 1.0% of the shares of the company are short sold. Based on an average trading volume of 2,968 shares, the short-interest ratio is presently 3.9 days.
Mannatech Price Performance
MTEX stock traded down $0.96 during trading on Tuesday, reaching $7.95. The company’s stock had a trading volume of 82,235 shares, compared to its average volume of 14,375. The company has a quick ratio of 0.56, a current ratio of 1.13 and a debt-to-equity ratio of 0.48. The company’s fifty day moving average is $9.07 and its 200-day moving average is $8.89. The company has a market capitalization of $15.11 million, a P/E ratio of -9.24 and a beta of 0.79. Mannatech has a 1 year low of $6.90 and a 1 year high of $16.49.
Mannatech (NASDAQ:MTEX – Get Free Report) last released its quarterly earnings data on Wednesday, November 12th. The company reported $1.01 earnings per share for the quarter. Mannatech had a negative return on equity of 22.75% and a negative net margin of 1.50%.The firm had revenue of $29.16 million during the quarter.
Wall Street Analysts Forecast Growth
View Our Latest Stock Report on Mannatech
About Mannatech
Mannatech, Inc is a global health and wellness company that develops and markets a range of dietary supplements and personal care products through a direct selling business model. The company’s core focus is on glyconutrients, specialized carbohydrates believed to support cellular communication, which form the basis of many of its flagship offerings. Operating under a network marketing structure, Mannatech empowers independent associates to promote and distribute its products in markets around the world.
The company’s product portfolio includes nutritional supplements aimed at immune support, digestive health, and healthy aging, as well as skincare items designed to promote hydration and skin vitality.
Read More
- Five stocks we like better than Mannatech
- Bombshell Exposé on China Strikes
- Wall Street Stockpicker Names #1 Stock of 2026
- ALERT: Drop these 5 stocks before January 2026!
- Do not delete, read immediately
- A month before the crash
Receive News & Ratings for Mannatech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mannatech and related companies with MarketBeat.com's FREE daily email newsletter.
